Loading…
LifeVantage Corporation is projected to rise to $8.24 by 2027, a +28% move from its current price of $6.43. LFVN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $6.25 | $6.43 | $6.62 | +0.02% |
| Aug 6 | $6.17 | $6.43 | $6.71 | +0.05% |
| Aug 7 | $6.12 | $6.43 | $6.77 | +0.07% |
| Aug 8 | $6.07 | $6.44 | $6.83 | +0.10% |
| Aug 9 | $6.03 | $6.44 | $6.88 | +0.12% |
| Aug 10 | $5.99 | $6.44 | $6.92 | +0.15% |
| Aug 11 | $5.96 | $6.44 | $6.96 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.96 | $6.44 | $6.96 | +0.17% |
| Week 2 | $5.78 | $6.45 | $7.20 | +0.35% |
| Week 3 | $5.65 | $6.46 | $7.40 | +0.52% |
| Week 4 | $5.54 | $6.47 | $7.57 | +0.69% |
| Week 5 | $5.45 | $6.49 | $7.72 | +0.87% |
| Week 6 | $5.37 | $6.50 | $7.86 | +1.04% |
| Week 7 | $5.30 | $6.51 | $8.00 | +1.22% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LifeVantage Corporation is a consumer defensive company that engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, LifeVantage Omega+, LifeVantage ProBio, LifeVantage IC Bright, LifeVantage Daily Wellness, LifeVantage Rise AM and Reset PM System, LifeVantage D3+, PhysIQ Fat Burn, PhysIQ Prebiotic, MindBody GLP-1 System (MB Core and MB Enhance), Petandim for Dogs, and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name.
It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.
LifeVantage Corporation (LFVN) is a consumer defensive stock with a current price of $6.18 and a market cap of $77.97M, ranking 4249. The stock sits in a narrow market position but carries a long‑term forecast that shows growing potential across multiple years. The latest projections place steady price advancement from 2026 through 2050, with 2026–2030 yielding progressively higher averages and notable upside by 2030.
These figures are estimates and are not guarantees.
A major floor 37.5% below — a decisive break under it would weaken the trend.
The nearest floor, 5.4% below — buyers have tended to step in here.
The nearest ceiling, 3.4% above — a clean break opens room to run.
A major ceiling 66.4% above — clearing it would confirm fresh momentum.
Key LFVN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LFVN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.37 | Buy | $6.38 | Buy |
| MA 10 | $6.37 | Buy | $6.36 | Buy |
| MA 20 | $6.29 | Buy | $6.39 | Buy |
| MA 50 | $6.97 | Sell | $6.43 | Buy |
| MA 100 | $5.89 | Buy | $6.33 | Buy |
| MA 200 | $6.12 | Buy | $6.98 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.84 | Neutral |
| Stoch RSI (14) | 79.85 | Neutral |
| CCI (20) | 113.21 | Buy |
| Williams %R (14) | -28.57 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 3.71 | Buy |
| Bollinger %B (20,2) | 0.86 | Neutral |
| Stochastic %K (14) | 71.43 | Neutral |
| TRIX (15) | -0.33 | Sell |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 56.77 | Neutral |
| Momentum (10) | 0.23 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 6.36 | Buy |
| ADX (14) | 10.32 | Neutral |
| ATR (14) | 0.14 | Info |
The 30‑day technical picture is neutral, with RSI at 40. The 50‑day simple moving average sits at $6.73 and the 200‑day simple moving average at $6.28. The stock trades within a 30‑day range of $4.80 to $7.96, highlighting nearby support near $6.04 and resistance near $10.70.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.02 | $6.43 | $8.52 | 0% | Neutral | |
| $6.53 | $8.24 | $11.03 | +28% | Bullish | |
| $6.57 | $8.56 | $11.92 | +33% | Bullish | |
| $7.61 | $10.17 | $14.61 | +58% | Bullish | |
| $8.80 | $12.02 | $17.73 | +87% | Bullish | |
| $10.92 | $15.22 | $22.96 | +137% | Bullish | |
| $13.81 | $19.62 | $30.21 | +205% | Bullish | |
| $13.98 | $20.23 | $31.72 | +215% | Bullish | |
| $14.53 | $21.37 | $34.09 | +232% | Bullish | |
| $16.50 | $24.67 | $39.97 | +284% | Bullish | |
| $26.95 | $43.41 | $75.07 | +575% | Bullish | |
| $49.78 | $91.19 | $173.36 | +13.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.02 | $6.43 | $7.87 | +0.00% |
| September 2026 | $5.65 | $6.70 | $8.17 | +4.17% |
| October 2026 | $5.51 | $6.58 | $8.12 | -1.82% |
| November 2026 | $5.43 | $6.52 | $8.12 | -0.90% |
| December 2026 | $5.61 | $6.78 | $8.52 | +4.05% |
Click any year to see its month-by-month LFVN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
LifeVantage Corporation's 2026 outlook centres on $6.43, within a $4.02 to $8.52 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, LFVN could reach as high as $11.03, with a base case around $8.24 and support toward $6.53 — roughly +28% from $6.43. Momentum favours further upside here.
Expect LFVN to range from $6.57 to $11.92 through 2028. The $8.56 average target implies a +33% move from current prices. That is up +4% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The LFVN price prediction for 2029 points to an average of $10.17 (low $7.61, high $14.61) — a potential gain of +58% on today's $6.43. Momentum favours further upside here.
In 2030, LFVN is projected to trade between $8.80 and $17.73, averaging $12.02 — a potential gain of +87% from today's $6.43. That is up +18% on the projected 2029 average. Buyers look set to stay in control over this stretch.
LifeVantage Corporation's 2031 outlook centres on $15.22, within a $10.92 to $22.96 range. That is up +27% on the projected 2030 average. That marks a +137% change versus current levels. Momentum favours further upside here.
By 2032, LFVN could reach as high as $30.21, with a base case around $19.62 and support toward $13.81 — roughly +205% from $6.43. Buyers look set to stay in control over this stretch.
Expect LFVN to range from $13.98 to $31.72 through 2033. The $20.23 average target implies a +215% move from current prices. That is up +3% on the projected 2032 average. Momentum favours further upside here.
The LFVN price prediction for 2034 points to an average of $21.37 (low $14.53, high $34.09) — a potential gain of +232% on today's $6.43. Buyers look set to stay in control over this stretch.
In 2035, LFVN is projected to trade between $16.50 and $39.97, averaging $24.67 — a potential gain of +284% from today's $6.43. That is up +15% on the projected 2034 average. Momentum favours further upside here.
LifeVantage Corporation's 2040 outlook centres on $43.41, within a $26.95 to $75.07 range. That is up +76% on the projected 2035 average. That marks a +575% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, LFVN could reach as high as $173.36, with a base case around $91.19 and support toward $49.78 — roughly +13.2x from $6.43. Momentum favours further upside here.
Investing $1,000 in LFVN today (≈ 155.520995 LFVN) could be worth
$14,182.45
+$13,182.45 (+1318%) by 2050 · US Dollar
Based on the average projected LFVN price of $91.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LFVNwould be worth at today's price.
$1,000 invested in LFVN on Jul 31, 2025 (≈ 79.681274 LFVN) would be worth
$512.35
-$487.65 (-48.8%) today · 0.51× · US Dollar
Based on a LFVN entry price of $12.55 vs. today's $6.43.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.53 | $984.69 | -1.5% |
| 1 month ago | $6.25 | $1,028.8 | +2.9% |
| 3 months ago | $5.43 | $1,184.16 | +18.4% |
| 6 months ago | $5.51 | $1,166.97 | +16.7% |
| 1 year ago | $12.55 | $512.35 | -48.8% |
| All time (5.0y) ago | $7.9 | $813.92 | -18.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LFVN forecast.
Our base-case forecast reaches $13.00 around 2031.
Implied market cap at $13.00: $164.01M
The multi‑year forecast shows a rising trajectory with notable milestones. In 2030 the average price is projected to be $10.66, with a minimum of $7.34, a maximum of $16.77, and an implied ROI of 72.4. The forecast also points to a dramatic rise by 2040, with an average of $38.95 and an ROI of 530.2, ranging from $21.19 to $74.19.
By 2050, the average is projected at $80.52 with an ROI of 1203 and a range from $36.24 to $171.42. These projections illustrate substantial upside over the long term, though they remain estimates and are not guarantees.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $10.66, a low of $7.34, and a high of $16.77, with an ROI of 72.4.
Yes. The 2031 max is $22.84 and the 2032 max reaches $30.58, with higher prospects continuing in later years (2033 max $30.45, 2034 max $33.23, 2035 max $39.36), indicating potential to surpass $20.
Current price is $6.18 and market cap is $77.97M.
The 30‑day range is $4.80 to $7.96, with support at $6.04 and resistance at $10.70. RSI(14) is 40, and the SMA50 is $6.73 while the SMA200 is $6.28.
For 2040, the average is $38.95 with an ROI of 530.2, ranging from $21.19 to $74.19. For 2050, the average is $80.52 with an ROI of 1203, ranging from $36.24 to $171.42.
LifeVantage Corporation Community Discussion
0Share your LifeVantage Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.